Search research articles
Contact Us
Filters
Showing results (471-480 of 485) with videos related to
Page
of 49
Sort By:
JAMA Network Open
|
October 31, 2023
Postoperative Staphylococcus aureus Infections in Patients With and Without Preoperative Colonization
Darren P R Troeman, Derek Hazard, Leen Timbermont, et al.
JAMA
|
December 16, 2022
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
, Alisa M Higgins, Lindsay R Berry, et al.
The New England Journal of Medicine
|
February 25, 2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
, Anthony C Gordon, Paul R Mouncey, et al.
Intensive Care Medicine
|
July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Yaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
Plos Medicine
|
June 8, 2023
Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis observational cohort study (NeoOBS)
Neal J Russell, Wolfgang Stöhr, Nishad Plakkal, et al.
JAMA
|
March 22, 2022
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial
, Charlotte A Bradbury, Patrick R Lawler, et al.
Thorax
|
May 13, 2025
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial
Lennie Derde, Anthony C Gordon, Paul R Mouncey, et al.
The New England Journal of Medicine
|
October 27, 2023
Simvastatin in Critically Ill Patients with Covid-19
, Thomas E Hills, Elizabeth Lorenzi, et al.
Critical Care Medicine
|
May 8, 2026
Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP)
Madiha Hashmi, Rashan Haniffa, Deva Jayakumar, et al.
JAMA
|
April 11, 2023
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial
, Patrick R Lawler, Lennie P G Derde, et al.
Page
of 49
Search research articles
Search
Showing results (471-480 of 485) with videos related to
Sort By:
Page
of 49
JAMA Network Open
|
October 31, 2023
Postoperative Staphylococcus aureus Infections in Patients With and Without Preoperative Colonization
Darren P R Troeman, Derek Hazard, Leen Timbermont, et al.
JAMA
|
December 16, 2022
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
, Alisa M Higgins, Lindsay R Berry, et al.
The New England Journal of Medicine
|
February 25, 2021
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
, Anthony C Gordon, Paul R Mouncey, et al.
Intensive Care Medicine
|
July 12, 2021
Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial
Yaseen M Arabi, Anthony C Gordon, Lennie P G Derde, et al.
Plos Medicine
|
June 8, 2023
Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: A global neonatal sepsis observational cohort study (NeoOBS)
Neal J Russell, Wolfgang Stöhr, Nishad Plakkal, et al.
JAMA
|
March 22, 2022
Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial
, Charlotte A Bradbury, Patrick R Lawler, et al.
Thorax
|
May 13, 2025
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial
Lennie Derde, Anthony C Gordon, Paul R Mouncey, et al.
The New England Journal of Medicine
|
October 27, 2023
Simvastatin in Critically Ill Patients with Covid-19
, Thomas E Hills, Elizabeth Lorenzi, et al.
Critical Care Medicine
|
May 8, 2026
Ivermectin for Critically and Noncritically Ill Hospitalized Patients With COVID-19: Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP)
Madiha Hashmi, Rashan Haniffa, Deva Jayakumar, et al.
JAMA
|
April 11, 2023
Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial
, Patrick R Lawler, Lennie P G Derde, et al.
Page
of 49